Home/Investors/Qiming Venture Partners Qiming Venture Partners
Biotech Investor · 39 portfolio companies
Portfolio Companies
| Company | Stage | Valuation | Focus |
|---|
| Genocury Biotech | preclinical | — | Oncology |
| Zencore Biologics | platform | — | Oncology, Immunology |
| VivaVision Biotech | commercial | — | Ophthalmology |
| Tenacia Biotechnology | phase-1 | — | Oncology, Immunology |
| Lyvgen Pharma | phase-2 | — | Oncology, Immunology |
| InventisBio | phase-2 | — | Oncology, Metabolic Diseases |
| Immorna Biotherapeutics | preclinical | — | Infectious Diseases, Oncology |
| Laekna Therapeutics | phase-2 | — | Oncology |
| Impact Therapeutics | phase-3 | — | Oncology |
| ImmuneOnco Biopharma | phase-2 | — | Oncology, Immunology |
| Dizal Pharma | phase-2 | — | Oncology, Immunology |
| GenFleet Therapeutics | phase-2 | — | Oncology, Immunology |
| Full-Life Technologies | phase-2 | — | Oncology |
| Elpiscience | phase-1 | — | Oncology |
| Duality Biologics | phase-1 | — | Oncology |
| Convalife Pharmaceuticals | phase-2 | — | Cardiovascular, Metabolic |
| Antengene | commercial | — | Oncology, Immunology |
| Abbisko Therapeutics | phase-2 | — | Oncology |
| 3D Medicines | commercial | — | Oncology, Immunology |
| Thousand Oaks Biopharmaceuticals | phase-2 | — | Oncology, Immunology |
| TransThera Sciences | phase-2 | — | Oncology, Immunology |
| Eaglenos Sciences | preclinical | — | Oncology |
| Hexaell Biotech | phase-2 | — | Regenerative Medicine, Oncology |
| Insilico Medicine | platform | — | Oncology, Fibrosis |
| Yirui Pharma | phase-2 | — | Oncology, Immunology |
| Sciwind Biosciences | phase-2 | — | Metabolic |
| Lynk Pharmaceuticals | phase-2 | — | Oncology, Immunology |
| HighField Biopharmaceuticals | phase-2 | — | Oncology, Immunology |
| Bliss Biopharmaceutical | phase-1 | — | Oncology |
| Xiangxue Life Sciences | phase-2 | — | Oncology |
| MingMed Biotechnology | phase-2 | — | Oncology, Immunology |
| Excelmab | phase-2 | — | Oncology, Immunology |
| Keymed Biosciences | phase-2 | — | Oncology, Immunology |
| iSIA Bio-technology | preclinical | — | Oncology |
| Transcend Vivoscope | commercial | — | Oncology, Surgery |
| GrandOmics Biosciences | commercial | — | Genetics & Genomics, Diagnostics |
| CorreGene | preclinical | — | Rare Disease, Gene Therapy |
| BroadenBio | phase-2 | — | Oncology, Immunology |
| Avistone | phase-2 | — | Oncology |